Why it was recalled
Presence of Particulate Matter: Hair was found in a prefilled syringe
Product description
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
Lot numbers, UPCs & expiration codes
Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
Where it was sold
Nationwide within the United States.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0245-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 19, 2025
- FDA report date
- Jan 7, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Novo Nordisk Inc.
Original FDA data
Every field from FDA enforcement report D-0245-2026, exactly as published.
Show all FDA fields
- City
- Plainsboro
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98100
- Address
- 800 Scudders Mill Rd
- Code information
- Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
- Postal code
- 08536-1606
- Report date
- Jan 7, 2026
- Product type
- Drugs
- Recall number
- D-0245-2026
- Classification
- Class II
- Recalling firm
- Novo Nordisk Inc.
- Reason for recall
- Presence of Particulate Matter: Hair was found in a prefilled syringe
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
- Distribution pattern
- Nationwide within the United States.
- Recall initiation date
- Dec 19, 2025
- Initial firm notification
- Letter
- Center classification date
- Dec 31, 2025